NEW YORK (GenomeWeb) – Ambry Genetics announced this week that it has opened its AmbryShare data sharing program to the public. AmbryShare contains data on more than 1 million variants from 11,400 hereditary breast and ovarian cancer patients. It is comprised of de-identified aggregated allele frequency data that includes analysis of all genes in the human genome. The company is also soliciting collaborations with interested researchers for new AmbryShare exome projects on autism and prostate cancer.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.